BiotechTube

PRF-108 + Placebo + Ropivacaine + PRF-110

Phase 1/2Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pain

Conditions

Pain

Trial Timeline

Oct 1, 2010 → Apr 1, 2011

NCT ID
NCT00883194

About PRF-108 + Placebo + Ropivacaine + PRF-110

PRF-108 + Placebo + Ropivacaine + PRF-110 is a phase 1/2 stage product being developed by PainReform for Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00883194. Target conditions include Pain.

Hype Score Breakdown

Clinical
13
Activity
8
Company
2
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT00883194Phase 1/2Completed

Competing Products

20 competing products in Pain

See all competitors
ProductCompanyStageHype Score
PRF110- oily solution (Ropivacaine)PainReformPhase 2
44
PRF110PainReformPhase 2
44
TRV130 1.5 mg + TRV130 3 mg + TRV130 4.5 mg + Morphine 10 mg + PlaceboTrevenaPhase 1
25
Oliceridine + Placebo + MorphineTrevenaPhase 3
69
Oliceridine + Placebo + MorphineTrevenaPhase 3
69
TRV130TrevenaPhase 3
69
TRV130 + Morphine + PlaceboTrevenaPhase 2
44
TRV130TrevenaPhase 2
44
LY3556050 + PlaceboEli LillyPhase 2
52
Popliteal nerve block including liposomal bupivacaine + Adductor canal nerve block including liposomal bupivacaine + Continuous popliteal nerve block with normal saline + Popliteal nerve block with exclusively unencapsulated bupivacaine + Adductor canal nerve block with exclusively unencapsulated bupivacaine + Continuous popliteal nerve block with unencapsulated bupivacainePacira BiosciencesApproved
80
Nanoformed Piroxicam IR Tablet + Felden (piroxicam) Tablets + Brexidol (piroxicam) TabletsNanoform FinlandPhase 1
28
0.75% bupivacaine + .75% bupivacaine + .75% bupivacaineSI-BONEApproved
77
LY3526318 + PlaceboEli LillyPhase 2
52
LY3857210 + PlaceboEli LillyPhase 2
52
OK-101 0.05% + OK-101 0.1% + PlaceboOKYO PharmaPhase 2
44
YHD1119 + LyricaYuhanPhase 1
33
YHD1119 + LyricaYuhanPhase 1
33
YHD1119 + LyricaYuhanPhase 3
77
YHD1119 300mg + YHD1119 300mgYuhanPhase 1
33
pregabalin sustained release tablet + pregabalin immediate release capsuleYuhanApproved
85

Other Products from PainReform

RopivacainePhase 3
69
PRF110Phase 2
44
PRF110- oily solution (Ropivacaine)Phase 2
44